A new Cell Division study reports that linalool stabilizes the NR3C2 protein in gastric cancer cells, activating NFKBIZ and ...
A new study finds that the transcription factor FOXA1 suppresses ferroptosis in cervical cancer cells by directly activating ...
Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or ...
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine ...
High-grade serous ovarian cancer is an aggressive form of ovarian cancer, characterized in particular by high diversity among ...
Cancer cells that have lost one safeguard against DNA damage can become dependent on another, an enzyme called Wee1. Drugs ...
Cancer treatment pioneer Dennis Slamon received Albany Prize for breakthrough breast cancer research that transformed ...
Novocure (Nasdaq: NVCR) announced today that it has entered into a clinical trial collaboration and supply agreement with Verastem Oncology to evaluate the use of Novocure’s Tumor Treating Fields ...
A previously unknown mechanism required for cells to start proliferating has been identified. A combination of mathematical modelling and cell-based experiments shows that the enzyme WEE1 switches off ...
GSK’s Hesham Abdullah says novel cancer treatments and drug development advances are “creating opportunities that simply ...
The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results